|
Table 4a
|
|
O
|
Pathways in cancer
|
6.8E-14
|
T
|
positive regulation of biosynthetic process
|
1.7E-11
|
|
O
|
Pancreatic cancer
|
1.2E-07
|
T
|
positive regulation of macromolecule metabolic process
|
3.1E-11
|
|
T
|
protein complex assembly
|
3.7E-06
|
T
|
positive regulation of cellular biosynthetic process
|
3.5E-11
|
|
T
|
protein complex biogenesis
|
3.7E-06
|
T
|
positive regulation of nitrogen compound metabolic process
|
1.6E-10
|
|
CC
|
regulation of cell proliferation
|
3.9E-06
|
T
|
positive regulation of macromolecule biosynthetic process
|
4.4E-10
|
|
O
|
Bladder cancer
|
7.8E-06
|
R
|
response to endogenous stimulus
|
5.1E-10
|
|
S
|
regulation of protein kinase cascade
|
8.7E-06
|
CC
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
3.6E-09
|
|
AD
|
cell adhesion
|
9.0E-06
|
R
|
response to hormone stimulus
|
8.1E-09
|
|
AD
|
biological adhesion
|
9.8E-06
|
O
|
Pathways in cancer
|
1.0E-08
|
|
T
|
positive regulation of macromolecule metabolic process
|
1.0E-05
|
T
|
positive regulation of transcription
|
1.5E-08
|
|
Table 4b
|
|
A
|
regulation of cell death
|
3.6E-05
|
A
|
negative regulation of programmed cell death
|
1.0E-06
|
|
A
|
negative regulation of cell death
|
4.4E-05
|
CC
|
regulation of cell proliferation
|
3.5E-08
|
|
A
|
regulation of apoptosis
|
7.9E-05
|
CC
|
positive regulation of cell proliferation
|
1.9E-06
|
|
CC
|
cell proliferation
|
1.6E-05
|
CC
|
cell cycle
|
2.7E-04
|
|
M_l
|
regulation of lipid metabolic process
|
3.1E-05
|
CY
|
cytoskeleton organization
|
5.3E-06
|
|
M_l
|
positive regulation of lipid metabolic process
|
3.4E-04
|
CY
|
cell morphogenesis
|
2.0E-04
|
|
O
|
ErbB signaling pathway
|
5.2E-04
|
E
|
regulation of oxidoreductase activity
|
4.9E-04
|
| | | |
HY
|
response to hypoxia
|
8.7E-06
|
| | |
HY
|
response to reactive oxygen species
|
2.4E-04
|
| | | |
HY
|
response to hydrogen peroxide
|
6.3E-04
|
| | | |
IM
|
immune system development
|
4.1E-07
|
| | | |
IM
|
regulation of cytokine production
|
9.2E-07
|
| | | |
IM
|
regulation of cytokine biosynthetic process
|
2.8E-06
|
| | | |
IM
|
response to wounding
|
7.3E-05
|
| | | |
IM
|
positive regulation of cytokine biosynthetic process
|
1.1E-04
|
| | | |
IM
|
Signaling in Immune system
|
1.3E-04
|
| | | |
M_c
|
glucose metabolic process
|
5.1E-04
|
| | | |
M_l
|
regulation of lipid metabolic process
|
2.9E-04
|
| | | |
R
|
response to steroid hormone stimulus
|
4.5E-08
|
| | | |
R
|
response to nutrient levels
|
3.6E-07
|
| | | |
R
|
response to extracellular stimulus
|
6.8E-07
|
| | | |
R
|
response to drug
|
2.5E-06
|
| | | |
R
|
response to nutrient
|
3.7E-05
|
| | | |
R
|
response to vitamin
|
3.7E-05
|
| | | |
R
|
response to corticosteroid stimulus
|
4.3E-05
|
| | | |
R
|
response to glucocorticoid stimulus
|
9.1E-05
|
| | | |
R
|
response to lipopolysaccharide
|
1.7E-04
|
| | | |
R
|
response to abiotic stimulus
|
3.4E-04
|
| | | |
R
|
negative regulation of response to external stimulus
|
6.8E-04
|
| | | |
V
|
hemopoiesis
|
1.2E-07
|
| | | |
V
|
leukocyte differentiation
|
9.4E-06
|
| | | |
V
|
blood circulation
|
4.9E-05
|
| | | |
V
|
circulatory system process
|
4.9E-05
|
| | | |
V
|
lymphocyte differentiation
|
7.4E-05
|
| | | |
V
|
regulation of angiogenesis
|
1.1E-04
|
| | | |
V
|
blood vessel development
|
1.2E-04
|
| | | |
V
|
vasculature development
|
1.8E-04
|
